Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).

Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Peter I, Lober WB, Crothers K, Grunfeld C, Saag MS, Kitahata MM, Lloyd-Jones DM, Crane HM.

BMC Med. 2019 Jul 31;17(1):149. doi: 10.1186/s12916-019-1385-7.

2.

Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.

Crane HM, Nance RM, Heckbert SR, Ritchings C, Rosenblatt L, Budoff M, Wood BR, Tirschwell DL, Kim HN, Mathews WC, Geng E, Moore RD, Hunt PW, Eron JJ, Burkholder GA, Drozd DR, Chow FC, Becker KJ, Zunt JR, Ho EL, Kalani R, Huffer A, Whitney BM, Saag MS, Kitahata MM, Delaney JAC.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):e141-e147. doi: 10.1097/QAI.0000000000002071.

3.

Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings.

Nance RM, Vannappagari V, Smith K, Johannes CB, Calingaert B, Saltus CW, Mayer KH, Whitney BM, Rodriguez B, Moore RD, Eron JJ, Geng E, Mathews WC, Mugavero MJ, Saag MS, Kitahata MM, Delaney JAC, Crane HM.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):572-577. doi: 10.1097/QAI.0000000000002075.

4.

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.

Johnson VA, Cramer YS, Rosenkranz SL, Becker S, Klingman KL, Kallungal B, Coakley E, Acosta EP, Calandra G, Saag MS; NIH/NIAID AIDS Clinical Trials Group A5210 Protocol Team.

AIDS Res Hum Retroviruses. 2019 Aug;35(8):691-697. doi: 10.1089/AID.2018.0256. Epub 2019 Jun 18.

PMID:
31099252
5.

Impact of abstinence and of reducing illicit drug use without abstinence on HIV viral load.

Nance RM, Trejo MEP, Whitney BM, Delaney JAC, Altice F, Beckwith CG, Chander G, Chandler R, Christopoulous K, Cunningham C, Cunningham WE, Del Rio C, Donovan D, Eron JJ, Fredericksen RJ, Kahana S, Kitahata MM, Kronmal R, Kuo I, Kurth A, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Ouellet LJ, Quan VM, Saag MS, Simoni JM, Springer S, Strand L, Taxman F, Young JD, Crane HM.

Clin Infect Dis. 2019 Apr 17. pii: ciz299. doi: 10.1093/cid/ciz299. [Epub ahead of print]

PMID:
30994900
6.

HIV Viral Suppression Trends.

Simoni JM, Nance RM, Whitney BM, Saag MS, Crane HM.

Ann Intern Med. 2019 Apr 16;170(8):582-583. doi: 10.7326/L19-0067. No abstract available.

PMID:
30986840
7.

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia.

Hudson FP, Mulenga L, Westfall AO, Warrier R, Mweemba A, Saag MS, Stringer JS, Eron JJ, Chi BH.

Antivir Ther. 2019 Apr 12. doi: 10.3851/IMP3299. [Epub ahead of print]

PMID:
30977467
8.

Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study.

Kim HN, Nance RM, Williams-Nguyen JS, Chris Delaney JA, Crane HM, Cachay ER, Martin J, Mathews WC, Chander G, Franco R, Hurt CB, Geng EH, Rodriguez B, Moore RD, Saag MS, Kitahata MM; Centers for AIDS Research Network of Integrated Clinical Systems.

Open Forum Infect Dis. 2019 Mar 23;6(4):ofz100. doi: 10.1093/ofid/ofz100. eCollection 2019 Apr.

9.

Physical Functioning Among Patients Aging With Human Immunodeficiency Virus (HIV) Versus HIV Uninfected: Feasibility of Using the Short Physical Performance Battery in Clinical Care of People Living With HIV Aged 50 or Older.

Crane HM, Miller ME, Pierce J, Willig AL, Case ML, Wilkin AM, Brown S, Asirot MG, Fredericksen RJ, Saag MS, Landay AL, High KP.

Open Forum Infect Dis. 2019 Mar 11;6(3):ofz038. doi: 10.1093/ofid/ofz038. eCollection 2019 Mar.

10.

Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain.

Merlin JS, Long D, Becker WC, Cachay ER, Christopolous KA, Claborn KR, Crane HM, Edelman EJ, Lovejoy TI, Mathews WC, Morasco BJ, Napravnik S, OʼCleirigh C, Saag MS, Starrels JL, Gross R, Liebschutz JM.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):231-237. doi: 10.1097/QAI.0000000000001998.

PMID:
30865181
11.

Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART.

Eaton EF, Tamhane A, Davy-Mendez T, Moore RD, Mathews WC, Saag MS, Mugavero MJ, Wyatt CM, Gutierrez OM.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):e6-e9. doi: 10.1097/QAI.0000000000001999.

PMID:
30865178
12.

Associations of food insecurity and psychosocial measures with diet quality in adults aging with HIV.

Muhammad JN, Fernandez JR, Clay OJ, Saag MS, Overton ET, Willig AL.

AIDS Care. 2019 May;31(5):554-562. doi: 10.1080/09540121.2018.1554239. Epub 2018 Dec 17.

PMID:
30558446
13.

Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment-Reply.

Saag MS, Günthard HF, Smith DM.

JAMA. 2018 Nov 27;320(20):2154. doi: 10.1001/jama.2018.15946. No abstract available.

PMID:
30480722
14.

Physical Activity Intensity is Associated with Symptom Distress in the CNICS Cohort.

Webel AR, Willig AL, Liu W, Sattar A, Boswell S, Crane HM, Hunt P, Kitahata M, Matthews WC, Saag MS, Lederman MM, Rodriguez B.

AIDS Behav. 2019 Mar;23(3):627-635. doi: 10.1007/s10461-018-2319-7.

PMID:
30368620
15.

Chronic hepatitis B virus monoinfection at a university hospital in Zambia.

Vinikoor MJ, Sinkala E, Kanunga A, Muchimba M, Nsokolo B, Chilengi R, Wandeler G, Mulenga J, Chisenga T, Bhattacharya D, Saag MS, Foster G, Fried MW, Kelly P.

World J Hepatol. 2018 Sep 27;10(9):622-628. doi: 10.4254/wjh.v10.i9.622.

16.

Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.

Delaney JA, Nance RM, Whitney BM, Crane HM, Williams-Nguyen J, Feinstein MJ, Kaplan RC, Hanna DB, Budoff MJ, Drozd DR, Burkholder G, Mugavero MJ, Mathews WC, Moore RD, Eron JJ, Hunt PW, Geng E, Saag MS, Kitahata MM, Heckbert SR.

Epidemiology. 2019 Jan;30(1):69-74. doi: 10.1097/EDE.0000000000000930.

PMID:
30273188
17.

A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug Use.

Eaton EF, Mathews RE, Lane PS, Paddock CS, Rodriguez JM, Taylor BB, Saag MS, Kilgore ML, Lee RA.

Clin Infect Dis. 2019 Mar 5;68(6):1041-1043. doi: 10.1093/cid/ciy722.

PMID:
30165395
18.

HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.

Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, Aunon FM, Safren SA, Mugavero MJ, Mathews WC, Christopoulos KA, Eron JJ, Napravnik S, Moore RD, Rodriguez B, Lau B, Fredericksen RJ, Saag MS, Kitahata MM, Crane HM.

Ann Intern Med. 2018 Sep 18;169(6):376-384. doi: 10.7326/M17-2242. Epub 2018 Aug 21.

19.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ Jr, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA.

JAMA. 2018 Jul 24;320(4):379-396. doi: 10.1001/jama.2018.8431.

20.

Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Delaney JA, Nance RM, Whitney BM, Altice FL, Dong X, Trejo MEP, Matsuzaki M, Taxman FS, Chander G, Kuo I, Fredericksen R, Strand LN, Eron JJ, Geng E, Kitahata MM, Mathews WC, Mayer K, Moore RD, Saag MS, Springer S, Chandler R, Kahana S, Crane HM.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):283-287. doi: 10.1097/QAI.0000000000001803.

PMID:
30036277
21.

Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.

Nance RM, Crane HM, Ritchings C, Rosenblatt L, Budoff M, Heckbert SR, Drozd DR, Mathews WC, Geng E, Hunt PW, Feinstein MJ, Moore RD, Hsue P, Eron JJ, Burkholder GA, Rodriguez B, Mugavero MJ, Saag MS, Kitahata MM, Delaney JAC.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):916-921. doi: 10.1089/AID.2018.0053. Epub 2018 Aug 21.

PMID:
29984593
22.

Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.

Merlin JS, Long D, Becker WC, Cachay ER, Christopoulos KA, Claborn K, Crane HM, Edelman EJ, Harding R, Kertesz SG, Liebschutz JM, Mathews WC, Mugavero MJ, Napravnik S, C OʼCleirigh C, Saag MS, Starrels JL, Gross R.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):77-82. doi: 10.1097/QAI.0000000000001741.

23.

Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States.

Burkholder GA, Tamhane AR, Safford MM, Muntner PM, Willig AL, Willig JH, Raper JL, Saag MS, Mugavero MJ.

PLoS One. 2018 Mar 29;13(3):e0194940. doi: 10.1371/journal.pone.0194940. eCollection 2018.

24.

Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial.

Modi R, Amico KR, Knudson A, Westfall AO, Keruly J, Crane HM, Quinlivan EB, Golin C, Willig J, Zinski A, Moore R, Napravnik S, Bryan L, Saag MS, Mugavero MJ.

Contemp Clin Trials. 2018 Jun;69:48-54. doi: 10.1016/j.cct.2018.03.003. Epub 2018 Mar 8.

PMID:
29526609
25.

Point-of-Care Urine Ethyl Glucuronide Testing to Detect Alcohol Use Among HIV-Hepatitis B Virus Coinfected Adults in Zambia.

Vinikoor MJ, Zyambo Z, Muyoyeta M, Chander G, Saag MS, Cropsey K.

AIDS Behav. 2018 Jul;22(7):2334-2339. doi: 10.1007/s10461-018-2030-8.

26.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

27.

Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV.

Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, Napravnik S, Cropsey KL, Mugavero MJ, Saag MS, Hutton H, Lau B, Chander G.

Alcohol Clin Exp Res. 2018 Mar;42(3):561-570. doi: 10.1111/acer.13583. Epub 2018 Jan 29.

28.

Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure.

Eaton EF, Tamhane A, Davy-Mendez T, Mathews WC, Moore RD, Saag MS, Mugavero MJ.

AIDS. 2018 Jan 28;32(3):347-355. doi: 10.1097/QAD.0000000000001708.

29.

In Memorium: William Ernest Dismukes 1939-2017.

Pappas PG, Saag MS.

J Infect Dis. 2017 Sep 13. doi: 10.1093/infdis/jix480. [Epub ahead of print] No abstract available.

PMID:
28968670
30.

Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.

Moore T, Dembry LM, Saag MS.

J Infect Dis. 2017 Sep 15;216(suppl_5):S581-S587. doi: 10.1093/infdis/jix323.

31.

Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.

Barbian HJ, Jackson-Jewett R, Brown CS, Bibollet-Ruche F, Learn GH, Decker T, Kreider EF, Li Y, Denny TN, Sharp PM, Shaw GM, Lifson J, Acosta EP, Saag MS, Bar KJ, Hahn BH.

Retrovirology. 2017 Jun 2;14(1):35. doi: 10.1186/s12977-017-0359-0.

32.

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576. doi: 10.1097/QAI.0000000000001450.

33.

Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.

Cole SR, Edwards JK, Hall HI, Brookhart MA, Mathews WC, Moore RD, Crane HM, Kitahata MM, Mugavero MJ, Saag MS, Eron JJ; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Investigators.

Clin Infect Dis. 2017 Jun 1;64(11):1591-1596. doi: 10.1093/cid/cix199. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

34.

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.

Drozd DR, Saag MS, Westfall AO, Mathews WC, Haubrich R, Boswell SL, Cole SR, Porter D, Kitahata MM, Juday T, Rosenblatt L; CFAR Network of Integrated Clinical Systems (CNICS).

Medicine (Baltimore). 2017 Apr;96(14):e6275. doi: 10.1097/MD.0000000000006275.

35.

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.

Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, Merrill JO, Lau B, Mayer KH, Mugavero MJ, Mimiaga M, Willig JH, Burkholder GA, Drozd DR, Fredericksen RJ, Cropsey K, Moore RD, Simoni JM, Christopher Mathews W, Eron JJ, Napravnik S, Christopoulos K, Geng E, Saag MS, Kitahata MM.

AIDS Behav. 2017 Jul;21(7):1914-1925. doi: 10.1007/s10461-017-1740-7.

36.

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA.

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

37.

Diminished CD103 (αEβ7) Expression on Resident T Cells from the Female Genital Tract of HIV-Positive Women.

Moylan DC, Goepfert PA, Kempf MC, Saag MS, Richter HE, Mestecky J, Sabbaj S.

Pathog Immun. 2016 Fall-Winter;1(2):371-387. doi: 10.20411/pai.v1i2.166. Epub 2017 Jan 16.

38.

Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.

Vinikoor MJ, Sinkala E, Chilengi R, Mulenga LB, Chi BH, Zyambo Z, Hoffmann CJ, Saag MS, Davies MA, Egger M, Wandeler G; IeDEA- Southern Africa.

Clin Infect Dis. 2017 May 15;64(10):1343-1349. doi: 10.1093/cid/cix122. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

39.

Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.

Noorhasan M, Drozd DR, Grunfeld C, Merrill JO, Burkholder GA, Mugavero MJ, Willig JH, Willig AL, Cropsey KL, Mayer KH, Blashill A, Mimiaga M, McCaul ME, Hutton H, Chander G, Mathews WC, Napravnik S, Eron JJ, Christopoulos K, Fredericksen RJ, Nance RM, Delaney JC, Crane PK, Saag MS, Kitahata MM, Crane HM.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):534-545. doi: 10.1089/AID.2015.0357. Epub 2017 Feb 16.

40.

Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department.

Franco RA, Overton ET, Tamhane AR, Forsythe JM, Rodgers JB, Schexnayder JK, Guthrie D, Thogaripally S, Zinski A, Saag MS, Mugavero MJ, Wang HE, Galbraith JW.

Open Forum Infect Dis. 2016 Oct 4;3(4):ofw211. doi: 10.1093/ofid/ofw211. eCollection 2016 Oct.

41.

Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.

Crane HM, Paramsothy P, Drozd DR, Nance RM, Delaney JA, Heckbert SR, Budoff MJ, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Crane PK, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Rodriguez C, Peter I, Barnes GS, McReynolds J, Lober WB, Crothers K, Feinstein MJ, Grunfeld C, Saag MS, Kitahata MM; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort.

JAMA Cardiol. 2017 Mar 1;2(3):260-267. doi: 10.1001/jamacardio.2016.5139. Erratum in: JAMA Cardiol. 2017 Mar 1;2(3):346.

42.

The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.

Kim HN, Crane HM, Rodriguez CV, Van Rompaey S, Mayer KH, Christopoulos K, Napravnik S, Chander G, Hutton H, McCaul ME, Cachay ER, Mugavero MJ, Moore R, Geng E, Eron JJ, Saag MS, Merrill JO, Kitahata MM.

AIDS Behav. 2017 Jul;21(7):1878-1884. doi: 10.1007/s10461-016-1665-6.

43.

Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

Feinstein MJ, Nance RM, Drozd DR, Ning H, Delaney JA, Heckbert SR, Budoff MJ, Mathews WC, Kitahata MM, Saag MS, Eron JJ, Moore RD, Achenbach CJ, Lloyd-Jones DM, Crane HM.

JAMA Cardiol. 2017 Feb 1;2(2):155-162. doi: 10.1001/jamacardio.2016.4494.

44.

A Randomized Controlled Trial Protocol to Evaluate the Effectiveness of an Integrated Care Management Approach to Improve Adherence Among HIV-Infected Patients in Routine Clinical Care: Rationale and Design.

Crane HM, Fredericksen RJ, Church A, Harrington A, Ciechanowski P, Magnani J, Nasby K, Brown T, Dhanireddy S, Harrington RD, Lober WB, Simoni J, Safren SA, Edwards TC, Patrick DL, Saag MS, Crane PK, Kitahata MM.

JMIR Res Protoc. 2016 Oct 5;5(4):e156.

45.

Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012.

Saag MS, Westfall AO, Cole SR, Mathews WC, Drozd DR, Mayer KH, Burkholder GA, Kitahata M, Maiese EM; CFAR Network of Integrated Clinical Systems (CNICS).

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):60-64.

46.

Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders.

Crane HM, Nance RM, Merrill JO, Hutton H, Chander G, McCaul ME, Mathews WC, Fredericksen R, Simoni JM, Mayer K, Mugavero MJ, Willig JH, Burkholder G, Drozd DR, Mimiaga M, Lau B, Kim HN, Cropsey K, Moore RD, Christopoulos K, Geng E, Eron JJ, Napravnik S, Kitahata MM, Saag MS, Delaney JA.

AIDS Care. 2017 Feb;29(2):177-184. Epub 2016 Aug 2.

47.

Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research.

Eaton EF, Tamhane AR, Burkholder GA, Willig JH, Saag MS, Mugavero MJ.

Open Forum Infect Dis. 2016 Jun 16;3(2):ofw109. doi: 10.1093/ofid/ofw109. eCollection 2016 Apr.

48.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA.

JAMA. 2016 Jul 12;316(2):191-210. doi: 10.1001/jama.2016.8900.

49.

Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy.

Shepherd BE, Liu Q, Mercaldo N, Jenkins CA, Lau B, Cole SR, Saag MS, Sterling TR.

Stat Med. 2016 Oct 30;35(24):4335-4351. doi: 10.1002/sim.7007. Epub 2016 Jun 6.

50.

Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting.

Gibbons LE, Fredericksen R, Merrill JO, McCaul ME, Chander G, Hutton H, Lober WB, Mathews WC, Mayer K, Burkholder G, Willig JH, Mugavero MJ, Saag MS, Kitahata MM, Edwards TC, Patrick DL, Crane HM, Crane PK.

Drug Alcohol Depend. 2016 Jul 1;164:113-119. doi: 10.1016/j.drugalcdep.2016.04.038. Epub 2016 May 9.

Supplemental Content

Support Center